>>HomeContemporary issues

25.08.2009
InterMed Discovery aquires sustainable source for Omega-3 Fatty Acid
InterMed Discovery (IMD), a word class natural product lead-discovery company - based in the BioMedizinZentrumDortmund, anounced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This innovative microbial source has the potential to produce Omega-3 more sustainable and reliably compared to established sources.[more]
12.06.2009
Protagen and OncoTyrol form strategic alliance to validate the UNIarray® technology platform
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union. [more]
20.01.2009
InterMed Discovery Closes Equity Transaction Worth €7,44 M with Biotropics Malaysia Berhad
Dortmund, Germany, January 13, 2009 – InterMed Discovery (IMD), an emerging world class natural product lead-discovery company, today announced the close of an equity transaction worth €7.44 million with Biotropics Malaysia Berhad. [more]
29.10.2008
Chimera Biotech receives the European Frost & Sullivan Award 2008 for the Imperacer
The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec, a bioanalytical company based in the BioMedizinZentrumDortmund, Germany. Chimera Biotec is recognized for its pioneering Imperacer® ultrasensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzymelinked
Immunosorbent Assay). [more]
26.06.2008
Dortmund / Stockholm, Juni 2008: Process Relations introduces XperiDesk at Replisaurus Technologies
Process Relations establishes the Process Development Execution System (PDES) at the developers of the patented ECPR™ Technology.
[more]
18.01.2008
Protagen raises €1 million to expand its protein biochips business unit
Dortmund, Germany and New Jersey, USA, 15. January 2008: Protagen AG, a leading provider of products, services and software solutions for protein research, announces the closing of an interim financing round. The €1 million raised will be used to expand the company`s protein biochips business unit.[more]
25.10.2007
Process Relations, located in TechnologieZentrumDortmund, breaks new ground with the High-Tech Gründerfonds and SeedCapital Dortmund
The company based in Dortmund, Germany is commercializing and advancing the results of the EU 6th framework founded project "PROMENADE" and will help to structure and speed up the development of silicon based manufacturing processes.[more]
09.01.2007
600 sqm of microtechnology, advanced materials and manufactoring: IVAM joint pavilion shows ideas for new applications at Hannover Fair
In 2007 again entrepreneurs and developers from all over the world will meet at the trade fair Microtechnology embedded in Hannover Fair - the largest meeting point for industrial micro and nanotechnology.[more]
05.12.2006
Microtechnology sector grows: IVAM welcomes 200th member and forecasts more jobs
The 100 IVAM memeber companies in Germany employ about 7.500 preople. "Many people are not aware of the tremendous amount of jobs the microtechnology branch offers", says Dr. Jan Albers from Elmos Semiconductor AG, which employs about 670 people in Dortmund. IVAM supports companies like Elmos through technology marketing and networking[more]
29.11.2006
ELMOS subsidiary manufactures 40.000 pressure sensors per day
SMI production record - Package is also internally produced[more]
© 2010 TechnologieZentrumDortmund GmbH - Emil-Figge-Straße 76-80 - 44227 Dortmund